Publications by authors named "Justine Petitfour"
CSF β-amyloid is not a prognostic marker in multiple sclerosis patients.
Mult Scler Relat Disord
December 2022
Article Synopsis
- Multiple sclerosis (MS) is a chronic inflammatory disorder, and the study aimed to evaluate the potential of CSF β-amyloid-42 (Aβ42) and β-amyloid-40 (Aβ40) levels as prognostic biomarkers in MS patients.
- The research included 89 newly diagnosed MS patients and 27 controls, but found that CSF Aβ levels were similar across groups, with only age influencing Aβ levels, not MS severity.
- Ultimately, the study concluded that CSF amyloid levels do not serve as reliable prognostic biomarkers for disability in patients with recently diagnosed relapsing-remitting MS (RRMS).